味知香(605089) - 2025 Q3 - 季度财报

Financial Performance - The company's revenue for the third quarter was ¥188,259,675.42, representing a year-on-year increase of 2.61%[4] - The total profit for the quarter was ¥23,075,640.49, showing a decrease of 13.52% compared to the same period last year[4] - The net profit attributable to shareholders was ¥20,949,133.27, down 17.64% year-on-year[4] - The net profit excluding non-recurring gains and losses decreased by 24.76% to ¥18,492,985.14[4] - The basic earnings per share for the quarter was ¥0.15, a decline of 21.05% compared to the previous year[5] - The net profit attributable to shareholders for the year-to-date was ¥52,895,913.29, down 21.90% year-on-year[4] - Total operating revenue for the first three quarters of 2025 reached CNY 530,763,121.50, a 3.3% increase from CNY 510,604,605.66 in the same period of 2024[19] - Net profit for the first three quarters of 2025 was CNY 52,895,913.29, down 21.9% from CNY 67,724,508.49 in the first three quarters of 2024[21] - The company reported a total profit of CNY 63,373,977.09 for the first three quarters of 2025, a decrease of 13.7% from CNY 73,382,025.90 in the same period of 2024[20] - Operating profit for the first three quarters of 2025 was ¥35,529,860, down 51.9% from ¥73,963,363 in the first three quarters of 2024[30] - Net profit for the first three quarters of 2025 was ¥24,476,296, a decrease of 64.1% compared to ¥68,290,566 in the same period of 2024[30] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,393,221,904.47, an increase of 3.20% from the end of the previous year[5] - As of September 30, 2025, total assets amount to ¥1,393,221,904.47, an increase from ¥1,349,986,490.07 at the end of 2024[15] - The company's total assets as of September 30, 2025, amounted to ¥1,391,290,946, an increase from ¥1,350,839,578 at the end of 2024[26] - Current assets total ¥951,843,160.58, compared to ¥899,130,849.03 in the previous year[15] - Current assets totaled ¥932,466,467 as of September 30, 2025, compared to ¥898,983,937 at the end of 2024, reflecting a growth of 3.7%[26] - Total liabilities amount to ¥166,423,160.90, an increase from ¥128,938,222.51[16] - The company's total liabilities as of September 30, 2025, were ¥192,058,373, compared to ¥128,937,864 at the end of 2024, marking a rise of 48.9%[26] - The equity attributable to shareholders of the parent company is ¥1,226,798,743.57, slightly up from ¥1,221,048,267.56[16] - The company's equity totaled ¥1,199,232,573 as of September 30, 2025, down from ¥1,221,901,715 at the end of 2024, reflecting a decrease of 1.9%[27] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥131,387,178.47, reflecting a significant increase of 95.47%[4][9] - Operating cash flow for the first three quarters of 2025 was CNY 131,387,178.47, compared to CNY 67,217,631.47 in the same period of 2024, representing a 95.5% increase[23] - Cash generated from operating activities in the first three quarters of 2025 was ¥586,588,841, an increase from ¥551,855,170 in the same period of 2024[31] - Net cash flow from operating activities increased to $146,826,767.09 from $67,319,387.47, representing a growth of approximately 118% year-over-year[32] - Total cash inflow from investment activities surged to $1,919,904,216.09 compared to $579,631,793.31, indicating a significant increase of about 230%[32] - Cash outflow for investment activities rose to $2,182,041,791.86 from $1,094,889,185.02, reflecting an increase of approximately 99%[32] - Net cash flow from financing activities decreased to -$69,035,995.59 from -$122,015,174.82, showing an improvement of about 43%[32] Shareholder Information - The total number of common shareholders at the end of the reporting period is 13,745[11] - The top 10 shareholders hold a total of 76,236,804 shares, representing 55.24% of the total shares[11] - The company's repurchase account holds 1,380,052 shares, accounting for 1.00% of the total share capital[12] Research and Development - Research and development expenses increased to CNY 5,253,131.90, up 106.8% from CNY 2,535,615.99 in the previous year[19] - Research and development expenses increased to ¥5,253,132 in the first three quarters of 2025, up from ¥2,535,616 in the same period of 2024, representing a growth of 107.1%[29] Cash and Cash Equivalents - The company's cash and cash equivalents are reported at ¥8,536,527.04, down from ¥192,872,367.59[14] - Cash and cash equivalents at the end of the period were CNY 8,236,527.04, down from CNY 272,483,325.50 at the end of the same period last year[24] - The company's cash and cash equivalents decreased to ¥8,310,772 from ¥192,657,576 at the end of 2024, indicating a significant decline[25] - The ending balance of cash and cash equivalents dropped to $8,010,771.55 from $272,266,411.20, a decline of approximately 97%[32]